In contrast, later in 2023, a multisociety statement from gastroenterology and hepatology organizations, including the AGA, AASLD, ACG, ASGE, and NASPGHAN, advised against routine discontinuation of GLP-1 therapy, emphasizing individualized patient management and the use of point-of-care gastric ultrasound (POCUS) to assess aspiration risk [9]
"We can't tell you exactly what they are
Oxidative stress in autism spectrum disorder (ASD)-current progress of mechanisms and biomarkers
Because these medications affect the central nervous system, plaintiffs contend that mental-health effects are a foreseeable safety concern, even where the exact level of risk is not fully defined
No, Lipo C injections are not a weight loss treatment